The Claim
Bioavailability-enhanced curcuminoid (BE) preparations produce a clinically meaningful reduction in knee osteoarthritis pain, with a 29.7% improvement from baseline on the WOMAC pain scale, exceeding the 20% minimum clinically important difference (MCID) threshold.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A special form of curcumin, called bioavailability-enhanced curcuminoid, reduces knee osteoarthritis pain by about 30% on a standard pain scale. This improvement is larger than the 20% reduction doctors consider large enough for patients to actually feel a difference.
See the scientific wording
Bioavailability-enhanced curcuminoid (BE) preparations produce a clinically meaningful reduction in knee osteoarthritis pain, with a 29.7% improvement from baseline on the WOMAC pain scale, exceeding the 20% minimum clinically important difference (MCID) threshold; this suggests the effect is perceptible to patients.
Curcumin, the active ingredient in the turmeric extract, stops the knee joint from producing chemicals that cause inflammation and pain. It reduces swelling by blocking important inflammatory signals and protects the joint with antioxidants. With less irritation, the pain nerves in the knee calm down, so patients feel less pain.
What the research says
1 studyStudy: Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis
Special turmeric extracts that absorb better were found to reduce knee pain by about 30%, which is enough for patients to feel a real difference.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.